Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Ministerium für Soziales, Arbeit, Gesundheit und Demografie des Landes Rheinland-Pfalz | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Documentation of all patients undergoing inpatient treatment for SARS-CoV-2 infection with regard to clinical status at admission, medical history, inpatient treatment and course of disease. The aim is to create a risk stratification of the infection on the basis of clinical data as well as therapy and disease progression of the patients. This may also contribute to a better planning of resources.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| In-patients with SARS-CoV-2 infection | In-patients fulfilling the following criteria: SARS-CoV-2 infection In-patient treatment Written informed consent for participation in observational study No explicit medical exclusion criteria are stated to avoid selection bias. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Prospective oberservational registry | Other | Non interventional study. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Chest x-ray | presence of infiltrates | throughout study completion, in average 1.5 years |
| Chest CT | presence of infiltrates | throughout study completion, in average 1.5 years |
| Supportive care - ICU | number of patients with ICU treatment required | throughout study completion, in average 1.5 years |
| Supportive care - oxygen therapy | number of patients with oxygen therapy required | throughout study completion, in average 1.5 years |
| Supportive care - ventilation | number of patients with ventilation required | throughout study completion, in average 1.5 years |
| Medication | number of patients with medication changes | throughout study completion, in average 1.5 years |
| Therapeutic strategies | number of patients with ECMO required | throughout study completion, in average 1.5 years |
| Lab parameters | number of patients with significant changes in lab parameters | throughout study completion, in average 1.5 years |
Not provided
Not provided
Inclusion Criteria:
SARS-CoV-2 infection In-patient treatment Written informed consent for participation in observational study
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
About 110 hospitals in Rhineland-Palatinate (Germany) treating patients with SARS-CoV-2 infection.
All stationary treated patients with SARS-CoV-2 infection will be included.
Preferably all hospitals in Rhineland-Palatinate, Germany, treating patients with SARS-CoV-2 infection.
Consecutive enrolment of all patients fulfilling the patient selection criteria to avoid selection bias.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Anselm Gitt, MD | Stiftung IHF and Klinikum der Stadt Ludwigshafen | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Klinikum der Stadt Ludwigshafen am Rhein GmbH, Klinik für Herzchirurgie | Ludwigshafen | RLP | 67063 | Germany |
Not provided
Not provided
Not provided
Not provided
| Intra-hospital complications | number of patients with complications during hospital stay | throughout study completion, in average 1.5 years |
| Vital status at discharge | vital status at discharge: alive, dead | throughout study completion, in average 1.5 years |